Legal and Regulatory Aspects of Medical Cannabis in the United States
- PMID: 38100798
- DOI: 10.1213/ANE.0000000000006301
Legal and Regulatory Aspects of Medical Cannabis in the United States
Abstract
Federal and state laws in the United States governing the use of cannabis are rapidly evolving. Under federal law, marijuana and its derivatives remain schedule I, defined as substances having no currently accepted medical use and a high potential for abuse. Hemp and its derivatives, in contrast, have been removed from schedule I. At the state level, a majority of states have passed laws legalizing cannabis in some form, although these laws vary from state to state in terms of the extent to which use is permitted, approved medical uses, and the types of regulation placed on commercial activity and quality control. This inconsistency has contributed to uncertainty among medical providers and their patients. In this review, we provide a brief account of the evolution and current state of federal and state laws and regulatory agencies involved in overseeing medical cannabis use in the United States.
Copyright © 2023 International Anesthesia Research Society.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- State Medical Cannabis Laws. National Conferences State Legislatures. Updated February 3, 2022. Accessed February 22, 2022. https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx .
-
- The Editors of Encyclopaedia. Encyclopedia Britannica “cannabis.” 2022. Accessed March 1, 2022. https://www.britannica.com/plant/cannabis-plant .
-
- Controlled Substances Act, 21 USC 803-813 (1970). Accessed March 1, 2022.
-
- Agricultural Marketing Act, 7 USC 1621 (1946).
-
- Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153:199–215.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
